Longitude Capital Partners, LLC

Average Profitability
26.53%
Insider Buys Quantity
2
Insider Buys Sum
$10.87M
Insider Sells Quantity
5
Insider Sells Sum
$67.39M

Insider Activity of Longitude Capital Partners, LLC

The largest purchase of all time was on 2013-07-01 and amounted to 433352 shares of Esperion Therapeutics, Inc. for $6.07M.

The largest sale of all time was on 2017-12-08 and amounted to 2000000 shares of Collegium Pharmaceutical, Inc. for $34.68M.

Biography of Longitude Capital Partners, LLC

No biography is available at this moment.

2017-12-08SaleCollegium Pharmaceutical, Inc.
COLL
10 percent owner
2M
6.4738%
$17.34$34.68M+13.11%
2015-05-12PurchaseCollegium Pharmaceutical, Inc.
COLL
10 percent owner
400,000
3.1337%
$12.00$4.8M+44.38%
2014-11-18SaleEsperion Therapeutics, Inc.
ESPR
10 percent owner
10,208
0.0606%
$31.61$322,691+89.62%
2014-11-17SaleEsperion Therapeutics, Inc.
ESPR
10 percent owner
964,052
6.0879%
$32.79$31.61M+94.47%
2014-10-09SaleEsperion Therapeutics, Inc.
ESPR
10 percent owner
1,886
0.0124%
$30.00$56,580+121.58%
2014-10-07SaleEsperion Therapeutics, Inc.
ESPR
10 percent owner
23,854
0.1521%
$30.04$716,579+114.26%
2013-07-01PurchaseEsperion Therapeutics, Inc.
ESPR
10 percent owner
433,352
2.8238%
$14.00$6.07M+8.67%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.